|Bid||0.00 x 900|
|Ask||0.00 x 1000|
|Day's Range||27.28 - 27.69|
|52 Week Range||24.27 - 45.35|
|Beta (3Y Monthly)||0.71|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 4, 2019 - Nov 8, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.31|
One of Nashville’s newest duos broke ground Tuesday on a project that could create as many as 300 jobs. Ascension Saint Thomas and Acadia Healthcare are beginning construction on their $32 million, 76-bed behavioral health center in MetroCenter. The facility will be Saint Thomas’ first in Middle Tennessee dedicated solely to mental health.
How much are employees worth, in profit dollars, to some of the state's largest companies? It runs the gamut from $1,200 to more than $237,000 per employee.
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 3.39% and -1.08%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
A 2018 Transparency Market Research report found approximately 242 companies competing in the addiction treatment space.
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Solid global demand, substantial impact from the electron microscopy business and robust volume growth and productivity are likely to favor Thermo Fisher's (TMO) analytical instruments revenues.
Top-line growth and solid show by Population Health, Revenue Cycle and IT Works are likely to aid Cerner's (CERN) Q2 earnings. However, expected decline in bookings is likely to be a dampener.
Probable revenue growth in APAC and EMEA regions and higher Oncology revenues are likely to aid Varian Medical (VAR) in Q3 earnings. However, contraction in margins might be a dampener.
FRANKLIN, Tenn., July 18, 2019 -- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced that it will release its second quarter 2019.
Top-line growth and better-than-expected segmental performance are likely to aid McKesson (MCK) in Q1. However, rise in adjusted operating expenses is likely to be a dampener.
Acadia Healthcare (ACHC) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Ron Fincher has been replaced by a former Universal Health Services vice president — the same company where Acadia's new CEO was an executive.
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 9 percentage points since the end of the third quarter of 2018 as investors worried over the possible ramifications of rising interest rates and escalation of the trade war with China. The hedge funds and institutional investors we track typically invest more […]
Investors are always looking for growth in small-cap stocks like Acadia Healthcare Company, Inc. (NASDAQ:ACHC), with a...
Acadia Healthcare Company Inc NASDAQ/NGS:ACHCView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is high * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NegativeShort interest is extremely high for ACHC with more than 20% of shares on loan. This means that investors who seek to profit from falling equity prices are currently targeting ACHC. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $136 million over the last one-month into ETFs that hold ACHC are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
At the beginning of May, British financial website This is Money reported that Acadia was considering selling Priory group for approximately $1.3 billion, or £1 billion.